Combined anti-EGF receptor and anti-HER2 receptor therapy in breast cancer: a promising strategy ready for clinical testing-Reference-Cited by-同舟云学术

Combined anti-EGF receptor and anti-HER2 receptor therapy in breast cancer: a promising strategy ready for clinical testing

Published:2002-01 Issue:1 Volume:13 Page:8-9
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Baselga J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/13/1/8/19479963/8.pdf

Reference17 articles.

1. Untangling the ErbB signalling network;Yarden;Nat Rev Mol Cell Biol,2001

2. Epidermal growth factor-related peptides and their receptors in human malignancies;Salomon;Crit Rev Oncol Hematol,1995

3. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

4. Epidermal growth factor receptor: a marker of early relapse in breast cancer and tumor stage progression in bladder cancer; interactions with neu;Harris,1989

5. Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer;Baselga;J Clin Oncol,1996

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting protein quality control pathways in breast cancer;BMC Biology;2017-11-16

2. The Inhibitory Effect of Echinacea purpurea and Echinacea pallida on BT-549 and Natural Killer Cells;MOJ Cell Science & Report;2017-07-18

3. Decreased HCRP1 promotes breast cancer metastasis by enhancing EGFR phosphorylation;Biochemical and Biophysical Research Communications;2016-08

4. Inhibition of breast cancer progression by a novel histone deacetylase inhibitor, LW479, by down-regulating EGFR expression;British Journal of Pharmacology;2015-06-12

5. Food Increased the Bioavailability of BMS-690514, an Orally Active EGFR/HER2/VEGF Receptor Kinase Inhibitor, in Healthy Subjects;The Journal of Clinical Pharmacology;2012-09